See more : YungShin Global Holding Corporation (3705.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Aclarion, Inc. (ACONW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aclarion, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- NewMed Energy – Limited Partnership (DKDRF) Income Statement Analysis – Financial Results
- Raven Industries, Inc. (RAVN) Income Statement Analysis – Financial Results
- Anfield Energy Inc. (AEC.V) Income Statement Analysis – Financial Results
- Ningbo Fangzheng Automobile Mould Co.,Ltd. (300998.SZ) Income Statement Analysis – Financial Results
- Pinetree Capital Ltd. (PNP.TO) Income Statement Analysis – Financial Results
Aclarion, Inc. (ACONW)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.aclarion.com
About Aclarion, Inc.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 75.40K | 60.44K | 60.29K | 48.65K | 26.90K |
| Cost of Revenue | 75.73K | 65.30K | 69.18K | 66.25K | 63.18K |
| Gross Profit | -324.00 | -4.85K | -8.88K | -17.59K | -36.28K |
| Gross Profit Ratio | -0.43% | -8.03% | -14.73% | -36.16% | -134.90% |
| Research & Development | 873.34K | 1.09M | 787.85K | 1.05M | 1.74M |
| General & Administrative | 3.25M | 4.47M | 1.83M | 1.07M | 1.59M |
| Selling & Marketing | 757.00K | 537.07K | 330.81K | 336.37K | 653.94K |
| SG&A | 4.00M | 5.00M | 2.16M | 1.41M | 2.24M |
| Other Expenses | 0.00 | 800.00 | 800.00 | 2.00M | 800.00 |
| Operating Expenses | 4.88M | 6.09M | 2.94M | 4.46M | 3.98M |
| Cost & Expenses | 4.95M | 6.16M | 3.01M | 4.53M | 4.04M |
| Interest Income | 172.00 | 2.51K | 474.91K | 15.00 | 5.00K |
| Interest Expense | 608.29K | 1.51M | 476.48K | 156.06K | 5.00K |
| Depreciation & Amortization | 162.67K | 143.62K | 189.37K | 196.28K | 178.21K |
| EBITDA | -4.14M | -5.42M | -4.28M | -4.28M | -3.84M |
| EBITDA Ratio | -5,490.97% | -9,766.37% | -7,723.48% | -8,803.14% | -14,262.01% |
| Operating Income | -4.88M | -6.10M | -2.95M | -4.48M | -4.01M |
| Operating Income Ratio | -6,466.48% | -10,089.53% | -4,897.89% | -9,203.03% | -14,921.01% |
| Total Other Income/Expenses | -35.39K | -1.51M | -2.00M | -157.79K | -5.96K |
| Income Before Tax | -4.91M | -7.61M | -4.95M | -4.64M | -4.02M |
| Income Before Tax Ratio | -6,513.41% | -12,582.79% | -8,210.53% | -9,527.35% | -14,943.15% |
| Income Tax Expense | 0.00 | 1.51M | -1.42M | 155.13K | 4.84K |
| Net Income | -4.91M | -9.11M | -3.53M | -4.79M | -4.02M |
| Net Income Ratio | -6,513.41% | -15,074.73% | -5,862.46% | -9,846.21% | -14,961.12% |
| EPS | -8.82 | -23.88 | -62.44 | -84.63 | -71.16 |
| EPS Diluted | -8.82 | -23.88 | -62.44 | -84.63 | -71.16 |
| Weighted Avg Shares Out | 556.81K | 381.60K | 56.61K | 56.61K | 56.55K |
| Weighted Avg Shares Out (Dil) | 556.81K | 381.60K | 56.61K | 56.61K | 56.55K |
Source: https://incomestatements.info
Category: Stock Reports